Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Intangibles (2020 - 2025)

Pulse Biosciences has reported Intangibles over the past 6 years, most recently at $741000.0 for Q3 2025.

  • Quarterly results put Intangibles at $741000.0 for Q3 2025, down 46.54% from a year ago — trailing twelve months through Sep 2025 was $741000.0 (down 46.54% YoY), and the annual figure for FY2024 was $1.2 million, down 35.31%.
  • Intangibles for Q3 2025 was $741000.0 at Pulse Biosciences, down from $907000.0 in the prior quarter.
  • Over the last five years, Intangibles for PLSE hit a ceiling of $8.0 million in Q1 2021 and a floor of $741000.0 in Q3 2025.
  • Median Intangibles over the past 5 years was $2.1 million (2023), compared with a mean of $2.6 million.
  • Biggest five-year swings in Intangibles: soared 89.49% in 2021 and later plummeted 63.89% in 2022.
  • Pulse Biosciences' Intangibles stood at $1.9 million in 2021, then soared by 35.26% to $2.6 million in 2022, then decreased by 26.07% to $1.9 million in 2023, then plummeted by 35.31% to $1.2 million in 2024, then tumbled by 39.26% to $741000.0 in 2025.
  • The last three reported values for Intangibles were $741000.0 (Q3 2025), $907000.0 (Q2 2025), and $1.1 million (Q1 2025) per Business Quant data.